oncology innovation

Market Access

New policies are shaping the market access landscape, such as the introduction of the EU HTA for oncology medicines.

News

Isomab has presented landmark safety data at ESC, clearing the path for next-generation therapies to promote blood vessel growth in CAD.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.